Yes. Dabigatran, rivaroxaban, and apixaban are safe and effective compared with warfarin for preventing stroke in patients with nonvalvular atrial fibrillation. These novel oral anticoagulants (NOACs) are noninferior in reducing the number of strokes and systemic emboli and in lowering all-cause mortality while not increasing major bleeding complications and hemorrhagic events.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
novel oral
8
oral anticoagulants
8
stroke patients
8
patients nonvalvular
8
help desk
4
desk answers
4
answers novel
4
anticoagulants safely
4
safely prevent
4
prevent stroke
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!